- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Anthrax Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Anthrax Vaccines market size is estimated to be worth US$ 674 million in 2021 and is forecast to a readjusted size of USD 1101.7 million by 2028 with a CAGR of 7.3% during review period. Human Use accounting for % of the Anthrax Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Live Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anthrax Vaccines include Emergent BioSolutions, Merial, Merck, Zoetis, and Bayer Sanidad Animal, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anthrax Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Live Vaccines
Cell free PA Vaccines
Market segment by Application can be divided into
Human Use
Animal Use
The key market players for global Anthrax Vaccines market are listed below:
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anthrax Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anthrax Vaccines, with price, sales, revenue and global market share of Anthrax Vaccines from 2019 to 2022.
Chapter 3, the Anthrax Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anthrax Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anthrax Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anthrax Vaccines.
Chapter 13, 14, and 15, to describe Anthrax Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Anthrax Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anthrax Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Live Vaccines
1.2.3 Cell free PA Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Anthrax Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Human Use
1.3.3 Animal Use
1.4 Global Anthrax Vaccines Market Size & Forecast
1.4.1 Global Anthrax Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anthrax Vaccines Sales in Volume (2017-2028)
1.4.3 Global Anthrax Vaccines Price (2017-2028)
1.5 Global Anthrax Vaccines Production Capacity Analysis
1.5.1 Global Anthrax Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Anthrax Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anthrax Vaccines Market Drivers
1.6.2 Anthrax Vaccines Market Restraints
1.6.3 Anthrax Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Emergent BioSolutions
2.1.1 Emergent BioSolutions Details
2.1.2 Emergent BioSolutions Major Business
2.1.3 Emergent BioSolutions Anthrax Vaccines Product and Services
2.1.4 Emergent BioSolutions Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merial
2.2.1 Merial Details
2.2.2 Merial Major Business
2.2.3 Merial Anthrax Vaccines Product and Services
2.2.4 Merial Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Anthrax Vaccines Product and Services
2.3.4 Merck Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Zoetis
2.4.1 Zoetis Details
2.4.2 Zoetis Major Business
2.4.3 Zoetis Anthrax Vaccines Product and Services
2.4.4 Zoetis Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bayer Sanidad Animal
2.5.1 Bayer Sanidad Animal Details
2.5.2 Bayer Sanidad Animal Major Business
2.5.3 Bayer Sanidad Animal Anthrax Vaccines Product and Services
2.5.4 Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Colorado Serum
2.6.1 Colorado Serum Details
2.6.2 Colorado Serum Major Business
2.6.3 Colorado Serum Anthrax Vaccines Product and Services
2.6.4 Colorado Serum Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 PharmAthene
2.7.1 PharmAthene Details
2.7.2 PharmAthene Major Business
2.7.3 PharmAthene Anthrax Vaccines Product and Services
2.7.4 PharmAthene Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Tiankang
2.8.1 Tiankang Details
2.8.2 Tiankang Major Business
2.8.3 Tiankang Anthrax Vaccines Product and Services
2.8.4 Tiankang Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Biogénesis-Bago
2.9.1 Biogénesis-Bago Details
2.9.2 Biogénesis-Bago Major Business
2.9.3 Biogénesis-Bago Anthrax Vaccines Product and Services
2.9.4 Biogénesis-Bago Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 CAVAC
2.10.1 CAVAC Details
2.10.2 CAVAC Major Business
2.10.3 CAVAC Anthrax Vaccines Product and Services
2.10.4 CAVAC Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Rosenbusch
2.11.1 Rosenbusch Details
2.11.2 Rosenbusch Major Business
2.11.3 Rosenbusch Anthrax Vaccines Product and Services
2.11.4 Rosenbusch Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Agrovet
2.12.1 Agrovet Details
2.12.2 Agrovet Major Business
2.12.3 Agrovet Anthrax Vaccines Product and Services
2.12.4 Agrovet Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Vecol
2.13.1 Vecol Details
2.13.2 Vecol Major Business
2.13.3 Vecol Anthrax Vaccines Product and Services
2.13.4 Vecol Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 CVCRI
2.14.1 CVCRI Details
2.14.2 CVCRI Major Business
2.14.3 CVCRI Anthrax Vaccines Product and Services
2.14.4 CVCRI Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 IVPM
2.15.1 IVPM Details
2.15.2 IVPM Major Business
2.15.3 IVPM Anthrax Vaccines Product and Services
2.15.4 IVPM Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Prondil
2.16.1 Prondil Details
2.16.2 Prondil Major Business
2.16.3 Prondil Anthrax Vaccines Product and Services
2.16.4 Prondil Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 CDV
2.17.1 CDV Details
2.17.2 CDV Major Business
2.17.3 CDV Anthrax Vaccines Product and Services
2.17.4 CDV Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Indian Immunologicals
2.18.1 Indian Immunologicals Details
2.18.2 Indian Immunologicals Major Business
2.18.3 Indian Immunologicals Anthrax Vaccines Product and Services
2.18.4 Indian Immunologicals Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Botswana Vaccine Institute
2.19.1 Botswana Vaccine Institute Details
2.19.2 Botswana Vaccine Institute Major Business
2.19.3 Botswana Vaccine Institute Anthrax Vaccines Product and Services
2.19.4 Botswana Vaccine Institute Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Ceva Santé Animale
2.20.1 Ceva Santé Animale Details
2.20.2 Ceva Santé Animale Major Business
2.20.3 Ceva Santé Animale Anthrax Vaccines Product and Services
2.20.4 Ceva Santé Animale Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Intervac
2.21.1 Intervac Details
2.21.2 Intervac Major Business
2.21.3 Intervac Anthrax Vaccines Product and Services
2.21.4 Intervac Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 JOVAC
2.22.1 JOVAC Details
2.22.2 JOVAC Major Business
2.22.3 JOVAC Anthrax Vaccines Product and Services
2.22.4 JOVAC Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anthrax Vaccines Breakdown Data by Manufacturer
3.1 Global Anthrax Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anthrax Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anthrax Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Anthrax Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Anthrax Vaccines Manufacturer Market Share in 2021
3.5 Global Anthrax Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anthrax Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anthrax Vaccines Market Size by Region
4.1.1 Global Anthrax Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Anthrax Vaccines Revenue by Region (2017-2028)
4.2 North America Anthrax Vaccines Revenue (2017-2028)
4.3 Europe Anthrax Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Anthrax Vaccines Revenue (2017-2028)
4.5 South America Anthrax Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Anthrax Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anthrax Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Anthrax Vaccines Revenue by Type (2017-2028)
5.3 Global Anthrax Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anthrax Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Anthrax Vaccines Revenue by Application (2017-2028)
6.3 Global Anthrax Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anthrax Vaccines Sales by Type (2017-2028)
7.2 North America Anthrax Vaccines Sales by Application (2017-2028)
7.3 North America Anthrax Vaccines Market Size by Country
7.3.1 North America Anthrax Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Anthrax Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anthrax Vaccines Sales by Type (2017-2028)
8.2 Europe Anthrax Vaccines Sales by Application (2017-2028)
8.3 Europe Anthrax Vaccines Market Size by Country
8.3.1 Europe Anthrax Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Anthrax Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anthrax Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Anthrax Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Anthrax Vaccines Market Size by Region
9.3.1 Asia-Pacific Anthrax Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anthrax Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anthrax Vaccines Sales by Type (2017-2028)
10.2 South America Anthrax Vaccines Sales by Application (2017-2028)
10.3 South America Anthrax Vaccines Market Size by Country
10.3.1 South America Anthrax Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Anthrax Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anthrax Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Anthrax Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Anthrax Vaccines Market Size by Country
11.3.1 Middle East & Africa Anthrax Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anthrax Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anthrax Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anthrax Vaccines
12.3 Anthrax Vaccines Production Process
12.4 Anthrax Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anthrax Vaccines Typical Distributors
13.3 Anthrax Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Anthrax Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Anthrax Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 4. Emergent BioSolutions Major Business
Table 5. Emergent BioSolutions Anthrax Vaccines Product and Services
Table 6. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merial Basic Information, Manufacturing Base and Competitors
Table 8. Merial Major Business
Table 9. Merial Anthrax Vaccines Product and Services
Table 10. Merial Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Anthrax Vaccines Product and Services
Table 14. Merck Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Zoetis Basic Information, Manufacturing Base and Competitors
Table 16. Zoetis Major Business
Table 17. Zoetis Anthrax Vaccines Product and Services
Table 18. Zoetis Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bayer Sanidad Animal Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Sanidad Animal Major Business
Table 21. Bayer Sanidad Animal Anthrax Vaccines Product and Services
Table 22. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Colorado Serum Basic Information, Manufacturing Base and Competitors
Table 24. Colorado Serum Major Business
Table 25. Colorado Serum Anthrax Vaccines Product and Services
Table 26. Colorado Serum Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. PharmAthene Basic Information, Manufacturing Base and Competitors
Table 28. PharmAthene Major Business
Table 29. PharmAthene Anthrax Vaccines Product and Services
Table 30. PharmAthene Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Tiankang Basic Information, Manufacturing Base and Competitors
Table 32. Tiankang Major Business
Table 33. Tiankang Anthrax Vaccines Product and Services
Table 34. Tiankang Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Biogénesis-Bago Basic Information, Manufacturing Base and Competitors
Table 36. Biogénesis-Bago Major Business
Table 37. Biogénesis-Bago Anthrax Vaccines Product and Services
Table 38. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. CAVAC Basic Information, Manufacturing Base and Competitors
Table 40. CAVAC Major Business
Table 41. CAVAC Anthrax Vaccines Product and Services
Table 42. CAVAC Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Rosenbusch Basic Information, Manufacturing Base and Competitors
Table 44. Rosenbusch Major Business
Table 45. Rosenbusch Anthrax Vaccines Product and Services
Table 46. Rosenbusch Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Agrovet Basic Information, Manufacturing Base and Competitors
Table 48. Agrovet Major Business
Table 49. Agrovet Anthrax Vaccines Product and Services
Table 50. Agrovet Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Vecol Basic Information, Manufacturing Base and Competitors
Table 52. Vecol Major Business
Table 53. Vecol Anthrax Vaccines Product and Services
Table 54. Vecol Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. CVCRI Basic Information, Manufacturing Base and Competitors
Table 56. CVCRI Major Business
Table 57. CVCRI Anthrax Vaccines Product and Services
Table 58. CVCRI Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. IVPM Basic Information, Manufacturing Base and Competitors
Table 60. IVPM Major Business
Table 61. IVPM Anthrax Vaccines Product and Services
Table 62. IVPM Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Prondil Basic Information, Manufacturing Base and Competitors
Table 64. Prondil Major Business
Table 65. Prondil Anthrax Vaccines Product and Services
Table 66. Prondil Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. CDV Basic Information, Manufacturing Base and Competitors
Table 68. CDV Major Business
Table 69. CDV Anthrax Vaccines Product and Services
Table 70. CDV Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 72. Indian Immunologicals Major Business
Table 73. Indian Immunologicals Anthrax Vaccines Product and Services
Table 74. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Botswana Vaccine Institute Basic Information, Manufacturing Base and Competitors
Table 76. Botswana Vaccine Institute Major Business
Table 77. Botswana Vaccine Institute Anthrax Vaccines Product and Services
Table 78. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Ceva Santé Animale Basic Information, Manufacturing Base and Competitors
Table 80. Ceva Santé Animale Major Business
Table 81. Ceva Santé Animale Anthrax Vaccines Product and Services
Table 82. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Intervac Basic Information, Manufacturing Base and Competitors
Table 84. Intervac Major Business
Table 85. Intervac Anthrax Vaccines Product and Services
Table 86. Intervac Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. JOVAC Basic Information, Manufacturing Base and Competitors
Table 88. JOVAC Major Business
Table 89. JOVAC Anthrax Vaccines Product and Services
Table 90. JOVAC Anthrax Vaccines Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Global Anthrax Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Doses)
Table 92. Global Anthrax Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 93. Market Position of Manufacturers in Anthrax Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 94. Global Anthrax Vaccines Production Capacity by Company, (M Doses): 2020 VS 2021
Table 95. Head Office and Anthrax Vaccines Production Site of Key Manufacturer
Table 96. Anthrax Vaccines New Entrant and Capacity Expansion Plans
Table 97. Anthrax Vaccines Mergers & Acquisitions in the Past Five Years
Table 98. Global Anthrax Vaccines Sales by Region (2017-2022) & (M Doses)
Table 99. Global Anthrax Vaccines Sales by Region (2023-2028) & (M Doses)
Table 100. Global Anthrax Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 101. Global Anthrax Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 102. Global Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 103. Global Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
Table 104. Global Anthrax Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 105. Global Anthrax Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 106. Global Anthrax Vaccines Price by Type (2017-2022) & (USD/Dose)
Table 107. Global Anthrax Vaccines Price by Type (2023-2028) & (USD/Dose)
Table 108. Global Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 109. Global Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
Table 110. Global Anthrax Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 111. Global Anthrax Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 112. Global Anthrax Vaccines Price by Application (2017-2022) & (USD/Dose)
Table 113. Global Anthrax Vaccines Price by Application (2023-2028) & (USD/Dose)
Table 114. North America Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
Table 115. North America Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
Table 116. North America Anthrax Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 117. North America Anthrax Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 118. North America Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 119. North America Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
Table 120. North America Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 121. North America Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
Table 122. Europe Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
Table 123. Europe Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
Table 124. Europe Anthrax Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 125. Europe Anthrax Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 126. Europe Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 127. Europe Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
Table 128. Europe Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 129. Europe Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
Table 130. Asia-Pacific Anthrax Vaccines Sales by Region (2017-2022) & (M Doses)
Table 131. Asia-Pacific Anthrax Vaccines Sales by Region (2023-2028) & (M Doses)
Table 132. Asia-Pacific Anthrax Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 133. Asia-Pacific Anthrax Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 134. Asia-Pacific Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 135. Asia-Pacific Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
Table 136. Asia-Pacific Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 137. Asia-Pacific Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
Table 138. South America Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
Table 139. South America Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
Table 140. South America Anthrax Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 141. South America Anthrax Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 142. South America Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 143. South America Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
Table 144. South America Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 145. South America Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
Table 146. Middle East & Africa Anthrax Vaccines Sales by Region (2017-2022) & (M Doses)
Table 147. Middle East & Africa Anthrax Vaccines Sales by Region (2023-2028) & (M Doses)
Table 148. Middle East & Africa Anthrax Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 149. Middle East & Africa Anthrax Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 150. Middle East & Africa Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 151. Middle East & Africa Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
Table 152. Middle East & Africa Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 153. Middle East & Africa Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
Table 154. Anthrax Vaccines Raw Material
Table 155. Key Manufacturers of Anthrax Vaccines Raw Materials
Table 156. Direct Channel Pros & Cons
Table 157. Indirect Channel Pros & Cons
Table 158. Anthrax Vaccines Typical Distributors
Table 159. Anthrax Vaccines Typical Customers
List of Figures
Figure 1. Anthrax Vaccines Picture
Figure 2. Global Anthrax Vaccines Revenue Market Share by Type in 2021
Figure 3. Live Vaccines
Figure 4. Cell free PA Vaccines
Figure 5. Global Anthrax Vaccines Revenue Market Share by Application in 2021
Figure 6. Human Use
Figure 7. Animal Use
Figure 8. Global Anthrax Vaccines Revenue, (USD Million) & (M Doses): 2017 & 2021 & 2028
Figure 9. Global Anthrax Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Anthrax Vaccines Sales (2017-2028) & (M Doses)
Figure 11. Global Anthrax Vaccines Price (2017-2028) & (USD/Dose)
Figure 12. Global Anthrax Vaccines Production Capacity (2017-2028) & (M Doses)
Figure 13. Global Anthrax Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Anthrax Vaccines Market Drivers
Figure 15. Anthrax Vaccines Market Restraints
Figure 16. Anthrax Vaccines Market Trends
Figure 17. Global Anthrax Vaccines Sales Market Share by Manufacturer in 2021
Figure 18. Global Anthrax Vaccines Revenue Market Share by Manufacturer in 2021
Figure 19. Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Anthrax Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Anthrax Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Anthrax Vaccines Sales Market Share by Region (2017-2028)
Figure 23. Global Anthrax Vaccines Revenue Market Share by Region (2017-2028)
Figure 24. North America Anthrax Vaccines Revenue (2017-2028) & (USD Million)
Figure 25. Europe Anthrax Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Anthrax Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. South America Anthrax Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Anthrax Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Global Anthrax Vaccines Sales Market Share by Type (2017-2028)
Figure 30. Global Anthrax Vaccines Revenue Market Share by Type (2017-2028)
Figure 31. Global Anthrax Vaccines Price by Type (2017-2028) & (USD/Dose)
Figure 32. Global Anthrax Vaccines Sales Market Share by Application (2017-2028)
Figure 33. Global Anthrax Vaccines Revenue Market Share by Application (2017-2028)
Figure 34. Global Anthrax Vaccines Price by Application (2017-2028) & (USD/Dose)
Figure 35. North America Anthrax Vaccines Sales Market Share by Type (2017-2028)
Figure 36. North America Anthrax Vaccines Sales Market Share by Application (2017-2028)
Figure 37. North America Anthrax Vaccines Sales Market Share by Country (2017-2028)
Figure 38. North America Anthrax Vaccines Revenue Market Share by Country (2017-2028)
Figure 39. United States Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Anthrax Vaccines Sales Market Share by Type (2017-2028)
Figure 43. Europe Anthrax Vaccines Sales Market Share by Application (2017-2028)
Figure 44. Europe Anthrax Vaccines Sales Market Share by Country (2017-2028)
Figure 45. Europe Anthrax Vaccines Revenue Market Share by Country (2017-2028)
Figure 46. Germany Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Anthrax Vaccines Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Anthrax Vaccines Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Anthrax Vaccines Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Anthrax Vaccines Revenue Market Share by Region (2017-2028)
Figure 55. China Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Anthrax Vaccines Sales Market Share by Type (2017-2028)
Figure 62. South America Anthrax Vaccines Sales Market Share by Application (2017-2028)
Figure 63. South America Anthrax Vaccines Sales Market Share by Country (2017-2028)
Figure 64. South America Anthrax Vaccines Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Anthrax Vaccines Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Anthrax Vaccines Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Anthrax Vaccines Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Anthrax Vaccines Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Anthrax Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Anthrax Vaccines in 2021
Figure 76. Manufacturing Process Analysis of Anthrax Vaccines
Figure 77. Anthrax Vaccines Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
